Lantheus Holdings, Inc. (NASDAQ:LNTH) has received an average recommendation of “Buy” from the seven brokerages that are covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $21.00.

Several equities research analysts recently issued reports on LNTH shares. BidaskClub cut Lantheus Holdings from a “strong-buy” rating to a “buy” rating in a report on Thursday, August 17th. Jefferies Group LLC reiterated a “buy” rating and issued a $22.00 price objective (up from $18.00) on shares of Lantheus Holdings in a report on Wednesday, August 2nd. Zacks Investment Research cut Lantheus Holdings from a “buy” rating to a “hold” rating in a report on Wednesday, September 20th. Credit Suisse Group lifted their price objective on Lantheus Holdings from $14.00 to $19.00 and gave the stock a “neutral” rating in a report on Wednesday, August 2nd. Finally, Wells Fargo & Company upgraded Lantheus Holdings from a “market perform” rating to an “outperform” rating in a report on Thursday.

TRADEMARK VIOLATION NOTICE: “Lantheus Holdings, Inc. (LNTH) Given Average Recommendation of “Buy” by Analysts” was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this article on another site, it was illegally copied and republished in violation of United States & international copyright laws. The correct version of this article can be read at https://www.watchlistnews.com/lantheus-holdings-inc-lnth-given-average-recommendation-of-buy-by-analysts/1681547.html.

In other news, insider Michael P. Duffy sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $16.45, for a total transaction of $329,000.00. Following the transaction, the insider now directly owns 184,218 shares in the company, valued at approximately $3,030,386.10. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director David F. Burgstahler sold 6,000 shares of the business’s stock in a transaction that occurred on Friday, September 1st. The stock was sold at an average price of $17.10, for a total value of $102,600.00. Following the transaction, the director now owns 13,248 shares in the company, valued at $226,540.80. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 903,099 shares of company stock worth $15,443,485. Insiders own 2.30% of the company’s stock.

Several institutional investors have recently modified their holdings of the company. BNP Paribas Arbitrage SA boosted its holdings in shares of Lantheus Holdings by 75.7% during the 3rd quarter. BNP Paribas Arbitrage SA now owns 14,565 shares of the medical equipment provider’s stock worth $259,000 after purchasing an additional 6,274 shares during the last quarter. Smith Asset Management Group LP raised its position in shares of Lantheus Holdings by 828.5% during the 3rd quarter. Smith Asset Management Group LP now owns 223,869 shares of the medical equipment provider’s stock valued at $3,985,000 after buying an additional 199,759 shares during the period. American Century Companies Inc. raised its position in shares of Lantheus Holdings by 120.7% during the 3rd quarter. American Century Companies Inc. now owns 210,158 shares of the medical equipment provider’s stock valued at $3,741,000 after buying an additional 114,924 shares during the period. State Board of Administration of Florida Retirement System purchased a new stake in shares of Lantheus Holdings during the 3rd quarter valued at approximately $940,000. Finally, Wedge Capital Management L L P NC raised its position in shares of Lantheus Holdings by 96.3% during the 3rd quarter. Wedge Capital Management L L P NC now owns 79,700 shares of the medical equipment provider’s stock valued at $1,419,000 after buying an additional 39,100 shares during the period. Institutional investors and hedge funds own 85.03% of the company’s stock.

Lantheus Holdings (NASDAQ LNTH) traded down $0.30 during trading hours on Tuesday, hitting $22.30. The stock had a trading volume of 863,350 shares, compared to its average volume of 389,281. Lantheus Holdings has a 52-week low of $7.95 and a 52-week high of $23.00. The company has a debt-to-equity ratio of -3.05, a current ratio of 2.92 and a quick ratio of 2.43. The firm has a market cap of $836.38, a PE ratio of 19.91, a PEG ratio of 1.63 and a beta of 0.92.

Lantheus Holdings (NASDAQ:LNTH) last posted its earnings results on Thursday, November 2nd. The medical equipment provider reported $0.24 EPS for the quarter, beating the Zacks’ consensus estimate of $0.20 by $0.04. Lantheus Holdings had a negative return on equity of 44.05% and a net margin of 9.59%. The firm had revenue of $79.94 million for the quarter, compared to analysts’ expectations of $77.18 million. During the same period last year, the firm earned $0.15 EPS. The company’s quarterly revenue was up 9.4% on a year-over-year basis. equities research analysts expect that Lantheus Holdings will post 1.1 earnings per share for the current year.

About Lantheus Holdings

Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.

Analyst Recommendations for Lantheus Holdings (NASDAQ:LNTH)

Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.